2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)ethynyl)pyridine,
CTEP cpd,
RO 4956371,
RO-4956371,
RO4956371,
CTEP,
871362-31-1,
CTEP (RO4956371),
mGluR5 inhibitor,
2-chloro-4-((2,5-dimethyl-1-(4-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)ethynyl)pyridine,
CHEMBL3410223,
2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine,
[3H]CTEP,
C19H13ClF3N3O,
SCHEMBL608379,
GTPL6408,
GTPL6409,
DTXSID50469986,
EX-A095,
HMS3651N19,
AOB87758,
BCP06140,
2340AH,
BDBM50071375,
MFCD22665726,
s2861,
ZINC35996961,
AKOS027301517,
compound 3 [PMID: 25565255],
CS-0974,
KS-000006G1,
NCGC00386156-06,
AK279698,
AM808005,
AS-17058,
HY-15445,
QC-11673,
RO4956371,
FT-0749890,
RO 4956371,
SW219465-1,
A11968,
W-5971,
J-690373,
1-(3,5-bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(1h-tetrazol-5-yl)phenyl)thiourea,
2-?chloro-?4-?((2,?5-?dimethyl-?1-?(4-?(trifluoromethoxy)?phenyl)?-?1H-?imidazol-?4-?yl)?ethynyl)?pyridine,
D0H2LI,
GOHCTCOGYKAJLZ-UHFFFAOYSA-N,
CID11646823,
B1633,
Pyridine, 2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]-1H-imidazol-4-yl]ethynyl]-,